0:00
12:58
On 10 July NHS England published proposals for establishing an antimicrobial products subscription model for products that offer exceptional value to patients and the NHS. This builds on a recent pilot project that we co-led which paid companies a fixed annual fee for antimicrobials based on their value to the NHS, rather than the volume used. We speak with Sophie Cooper, NICE's senior scientific adviser, and David Glover, NHS England's assistant director of medicines analysis.
More episodes from "NICE Talks"
Don't miss an episode of “NICE Talks” and subscribe to it in the GetPodcast app.